Trans-aortic left ventricular thrombo-embolectomy following COVID-19 infection

Michael Janula1, Andre Navarro1, John Bonello2

  • 1Department of Cardiothoracic Surgery, Mater Dei Hospital, Msida, Malta.

Insights

A COVID-19 infection complicated a myocardial infarction, leading to a large left ventricular thrombus. Surgical removal was necessary due to the thrombus size and patient

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Thrombosis

Background:

  • Left ventricular thrombosis is a recognized complication following myocardial infarction.
  • COVID-19 is associated with a procoagulant state, increasing the risk of venous and arterial thrombosis.

Observation:

  • A patient with COVID-19 presented with non-ST elevation myocardial infarction (NSTEMI).
  • This NSTEMI led to a large, pedunculated apical thrombus within the left ventricle.

Findings:

  • Conservative management of the left ventricular thrombus was initially attempted.
  • Surgical thromboembolectomy became necessary for complete thrombus resection.
  • Transaortic access was utilized to avoid ventriculotomy in a patient with reduced left ventricular systolic function.

Implications:

  • This case highlights the potential for COVID-19 to exacerbate cardiac complications like left ventricular thrombosis after myocardial infarction.
  • The transaortic approach offers a viable surgical option for managing left ventricular thrombi, particularly in patients with compromised cardiac function.
  • Prompt diagnosis and intervention are crucial for managing complex thrombotic events in the context of COVID-19 and myocardial infarction.